Weshalb die Ionis Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 22. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 7,70 | 29,08 | 277,66% |
2 | 2001 | 10,50 | 25,50 | 142,86% |
3 | 2006 | 4,30 | 8,50 | 97,67% |
4 | 2000 | 5,75 | 10,50 | 82,61% |
5 | 2014 | 29,08 | 51,78 | 78,06% |
6 | 2012 | 5,45 | 7,70 | 41,28% |
7 | 2023 | 34,90 | 45,57 | 30,57% |
8 | 2007 | 8,50 | 11,01 | 29,53% |
9 | 2022 | 26,95 | 34,90 | 29,50% |
10 | 2019 | 45,98 | 53,34 | 16,01% |
11 | 2018 | 42,17 | 45,98 | 9,03% |
12 | 2015 | 51,78 | 55,43 | 7,05% |
13 | 2025 | 34,12 | 36,07 | 5,72% |
14 | 2010 | 7,63 | 7,77 | 1,83% |
15 | 2005 | 4,40 | 4,30 | -2,27% |
16 | 2017 | 47,08 | 42,17 | -10,43% |
17 | 2020 | 53,34 | 46,40 | -13,01% |
18 | 2003 | 6,30 | 5,36 | -14,92% |
19 | 2016 | 55,43 | 47,08 | -15,06% |
20 | 2008 | 11,01 | 9,18 | -16,62% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 25,50 | 6,30 | -75,29% |
2 | 2021 | 46,40 | 26,95 | -41,92% |
3 | 1999 | 9,20 | 5,75 | -37,50% |
4 | 2011 | 7,77 | 5,45 | -29,86% |
5 | 2024 | 45,57 | 34,12 | -25,13% |
6 | 1998 | 11,63 | 9,20 | -20,89% |
7 | 2004 | 5,36 | 4,40 | -17,91% |
8 | 2009 | 9,18 | 7,63 | -16,88% |
9 | 2008 | 11,01 | 9,18 | -16,62% |
10 | 2016 | 55,43 | 47,08 | -15,06% |
11 | 2003 | 6,30 | 5,36 | -14,92% |
12 | 2020 | 53,34 | 46,40 | -13,01% |
13 | 2017 | 47,08 | 42,17 | -10,43% |
14 | 2005 | 4,40 | 4,30 | -2,27% |
15 | 2010 | 7,63 | 7,77 | 1,83% |
16 | 2025 | 34,12 | 36,07 | 5,72% |
17 | 2015 | 51,78 | 55,43 | 7,05% |
18 | 2018 | 42,17 | 45,98 | 9,03% |
19 | 2019 | 45,98 | 53,34 | 16,01% |
20 | 2022 | 26,95 | 34,90 | 29,50% |